Analysis of the effect on immune recognition of the glycosylation of viral envelope based on the analysis of the HIV-1 envelope
DOI:
https://doi.org/10.61173/r3vwhd95Keywords:
HIV-1 virus, glycosylation, immune recognition, Env, gp120 proteinAbstract
This passage firstly presents the global overview of the Human immunodeficiency virus (HIV), then providing a comprehensive review of the difficulties in the development of vaccines against the HIV, focusing on glycosylation modification of the envelope protein. During the infection process of this virus, the glycosylation modification help the virus evade the monitoring of the immune system through a series of immune evasion mechanisms. The glycosylation modifications of the virus are mainly located on the envelope of the virus. During the formation process of the envelope, the core products Group-specific antigen exerts a vital influence and shows positive effects in the maturation of the surface envelope proteins. Also, the components of the viral envelope and the mechanisms of glycosylation are introduced. The envelope protein have a significant impact in the immune evasion. Also, the passage introduces the recent progress in the research on treatment for the virus. An overall review on the impact of glycosylation modifications on immune evasion mechanism of HIV-1 virus is helpful for the future research in this field.
References
[1] Lerner G, Weaver N, Anokhin B, et al. Advances in HIV-1 assembly. Viruses, 2022, 14(3): 478.
[2] He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduction and Targeted Therapy, 2024, 9(1): 194.
[3] He Lingling, Zhang Cheng, Zhou Rongrong, et al. The role of glycosylation modification in the process of enveloped virus infection. Chinese Journal of Experimental and Clinical Infectious Diseases (Electronic Edition), 2021, 15(01): 1.
[4] Zhao C, Li H, Swartz T H, et al. The HIV Env glycoprotein conformational states on cells and viruses. MBio, 2022, 13(2): e01825-21.
[5] Bennett A L, Henderson R. HIV-1 envelope conformation, allostery, and dynamics. Viruses, 2021, 13(5): 852.
[6] Feng T, Zhang J, Chen Z, et al. Glycosylation of viral proteins: Implication in virus–host interaction and virulence. Virulence, 2022, 13(1): 670-683.
[7] Pandey V K, Sharma R, Prajapati G K, et al. N-glycosylation, a leading role in viral infection and immunity development. Molecular Biology Reports, 2022, 49(8): 8109-8120.
[8] Rao P G, Lambert G S, Upadhyay C. Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells. Journal of Virology, 2023, 97(9): e00710-23.
[9] Byrne G, O’Rourke S M, Alexander D L, et al. CRISPR/ Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation. PLoS Biology, 2018, 16(8): e2005817.
[10] Tailor M W, Chahine E B, Koren D, et al. Lenacapavir: a novel long-acting capsid inhibitor for HIV. Annals of Pharmacotherapy, 2024, 58(2): 185-195.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
